Xintian Pharma(SZ:002873)2022-11-13 23:12Group 1: Company Overview - Guizhou Xintian Pharmaceutical Co., Ltd. is listed under stock code 002873 and bond code 128091 [1] - The investor relations activity took place on November 10, 2022, in Shanghai [2] Group 2: Market Strategy - The company aims to ensure the growth of its leading products through clinical efficacy-driven marketing strategies [2][3] - Key strategies include optimizing marketing structure, enhancing brand promotion, and expanding market channels, particularly in lower-tier markets [3][4] Group 3: Research and Development Plans - The company focuses on two main areas: deepening expertise in gynecology and monitoring long-term market value [3] - Plans to increase R&D budget significantly in the coming year, with ongoing projects in innovative Chinese medicine, formula granules, and classic prescriptions [3][4] - The company has completed clinical trials for three innovative drugs and plans to apply for market approval in 2023 [3] Group 4: Production and Cost Management - The company has implemented smart manufacturing solutions to reduce production and labor costs, aiming for an annual output value exceeding 3 billion yuan [5] - New intelligent production lines and warehouses are expected to enhance efficiency and cost control [5] Group 5: Employee Incentives - The company plans to continue stock incentive programs for core positions to align employee growth with corporate development [5] - Emphasis on talent acquisition and internal performance evaluation to foster a motivated workforce [5]